Search for: "ELI LILLY & CO." Results 881 - 900 of 1,007
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2008, 10:35 pm
Eli Lilly & Co reportedly trained sales people to downplay the risks associated with the drug Zyprexa and to promote its use beyond the approved treatments for schizophrenia and bipolar disorder. [read post]
1 Aug 2008, 7:24 am
Yesterday Mr Justice Kitchin delivered a mega-judgment in Eli Lilly & Co v Human Genome Sciences Inc, [2008] EWHC 1903 (Pat), yet another significant Patents Court for England and Wales decision on patent validity.In short, HGS owned a patent that disclosed the nucleotide and amino acid sequence of a novel member of the TNF ligand superfamily, the polypeptide Neutrokine-Ã [read post]
1 Aug 2008, 1:34 am
Court documents filed in Alaska's lawsuit against Eli Lilly & Co. over its marketing of the antipsychotic medication Zyprexa say that the drugmaker encouraged its sales division to downplay the risks of the drug in order to boost profits. [read post]
18 Jul 2008, 8:34 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU Commission adopts proposal to extend copyright protection to performing artists from 50 to 95 years: (IPKat), (Out-Law), (IP Law360), (Patry Copyright Blog), (IPEG), (Techdirt), (Techdirt),  ‘Triway’ USPTO, EPO, JPO patent work-sharing pilot starts 28 July: (IP Updates), (Patent Docs), (Patent Prospector), (EPO),… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning… [read post]
7 Jul 2008, 10:59 am
Eli Lilly & Co., No. 181/07, Ontario Superior Court of Justice, Divisional Court (Toronto) (July 2, 2008). [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
30 Jun 2008, 4:25 pm
Drugmaker Eli Lilly & Co., which makes synthetic insulin, was sued after a fatal crash in Prince George's County, Maryland, caused by a diabetic driver who hadn't followed her doctor's orders on the use of one of her drugs. [read post]
30 Jun 2008, 1:43 pm
Drug companies such as Eli Lilly & Co, Japan's Daiichi Sankyo Co. and... [read post]
30 May 2008, 9:09 am
: (IP ThinkTank), (further discussion from IAM and e^(ip)) Illusory world of trade secret protection – Discussion of S Schreter’s article ‘Inside entrepreneurship: Patent protection isn’t only option’: (IPBiz)   Global – Copyright Illegal art: (Patry Copyright Blog),     Events 1-3 June: ACC Europe 2008 annual conference ‘Becoming a global legal manager: Developing the skills you will need to manage the… [read post]
10 May 2008, 4:40 am
Eli Lilly & Co., 639 N.E.2d 258, 261 (Ind. 1994). [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
1 May 2008, 11:21 am
Sturm, Ruger & Co., 761 N.Y.S.2d 192 (N.Y.A.D. 2003), the court held, among a lot of other things, that using public nuisance against makers of legal products would invite "a host of societal problems. . . into the courthouse":[A] common-law public nuisance cause of action. . .will, in our judgment, likely open the courthouse doors to a flood of limitless, similar theories of public nuisance, not only against these defendants, but also against a wide and varied array of… [read post]